4//SEC Filing
Hamilton James C 4
Accession 0001830755-25-000005
CIK 0000879407other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 5:59 PM ET
Size
6.7 KB
Accession
0001830755-25-000005
Insider Transaction Report
Form 4
Hamilton James C
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-08-13$20.00/sh−611$12,220→ 271,511 total - Sale
Common Stock
2025-08-15$20.00/sh−9,389$187,780→ 262,122 total
Footnotes (2)
- [F1]Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001830755
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 5:59 PM ET
- Size
- 6.7 KB